Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Durbin: Some Republicans waiting on ACA repeal to fail to start bipartisan talks

U.S. Sen. Dick Durbin, D-Illinois, believes opponents of the Senate’s Better Care Reconciliation Act (BCRA) can use a delay in considering the bill to convince undecided Republicans to block it, particularly now that health insurers have come out strongly against the legislation.

Thumbnail

Hospitals remain opposed to Senate healthcare bill; AMA sees slight improvement

Whenever Republicans in the House or Senate have released a new version of an Affordable Care Act (ACA) replacement plan in 2017, healthcare industry reaction has been almost uniformly negative. The same can largely be said for the newest version of the Better Care Reconciliation Act (BCRA), with the notable exception of the American Medical Association (AMA) when it comes to two provisions. 

Thumbnail

New Senate healthcare bill allows insurance plans with fewer benefits, keeps Medicaid cuts

Senate Republicans have released a new version of their Affordable Care Act (ACA) replacement plan, adding new funding for stabilizing the individual market and keeping more of the ACA’s taxes, while also including a controversial proposal to allow insurance plans which don’t comply with ACA regulations on benefits and community rating.

Thumbnail

House passes FDA user fee reauthorization, Senate schedule unclear

The House has passed legislation to reauthorize user fee programs through the Food and Drug Administration (FDA) affecting medical devices, prescription and generic drugs.

Thumbnail

AHIP: Market instability, higher premiums for sicker enrollees under Cruz amendment

America’s Health Insurance Plans (AHIP), health insurers’ largest lobbying group, has been largely silent on Senate Republicans’ version on an Affordable Care Act (ACA) replacement plan, but now is warning against a conservative amendment to allow insurers to now offer plans which don’t comply with ACA regulations.

HHS approves Alaska reinsurance program to shore up ACA market

Alaska will receive $323 million from HHS from 2018 to 2022 for a reinsurance program to offset claims from high-cost patients for the lone insurer offering coverage on its Affordable Care Act exchange.

Senate delaying August recess to work on healthcare bill

Senate Majority Leader Mitch McConnell, R-Kentucky, has taken the unusual step of delaying the Senate’s August recess, announcing the chamber will stay in session during the first two weeks of the month to address legislative priorities like the replacement of the Affordable Care Act.

Thumbnail

CMS: Fewer insurer sign-ups on exchange show ACA is ‘failing’

The number of applications for insurers planning to participate in the Affordable Care Act’s exchanges for 2018 has fallen by 38 percent, according to CMS.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup